TP53 and prostate carcinoma: Previous studies [52,53] have identified altered signals in prostate cancer such as TP53, androgen, and Forkhead box protein A1 (FOXA1) signaling, DNA repair, and phosphoinositide3-kinase (PI3K)–AKT signaling.